Dr Reddy’s Labs Q3 FY25 profit up 2% YoY at Rs. 1,413 Cr
The revenue from operations in Q3 FY25 is Rs. 8,358.6 crore, up 16% YoY
The revenue from operations in Q3 FY25 is Rs. 8,358.6 crore, up 16% YoY
Morepen Laboratories approves hiving off of medical devices business
The scheme is fully digitized and covers approximately 45% of India's population
The report also revealed that 87% of physicians agreed that FEE recommendations would help to improve the speed of recovery
Tyvek with Renewable Attribution is designed to help reduce the carbon footprint
Fludrocortisone acetate tablets will be produced at the Group's manufacturing site at Moraiya, Ahmedabad
Clariant is launching high-performing pharmaceutical ingredients to support the evolution of safe and effective medicines
Stringent regulatory environments can make OEMs reluctant to change processes and materials for approved medical devices
Subscribe To Our Newsletter & Stay Updated